Preoperative evaluation and perioperative management of patients undergoing major vascular surgery

Area of Science:

• Cardiology
• Vascular Surgery
• Perioperative Medicine

Background:

• Major vascular surgery poses a significant risk for major adverse cardiovascular events (MACE).
• Effective risk stratification and optimization of cardiac risk factors are essential for this patient population.
• Comorbidities like coronary artery disease and heart failure increase perioperative MACE risk.

Purpose of the Study:

• To present a current approach to cardiac risk stratification before major vascular surgery.
• To evaluate the utility and limitations of various cardiac risk indices.
• To review the role of cardiac testing and perioperative pharmacotherapies.

Main Methods:

• Review of current literature on cardiac risk assessment in vascular surgery.
• Analysis of different cardiac risk indices and their clinical application.
• Discussion of noninvasive and invasive cardiac diagnostic modalities.
• Overview of evidence-based perioperative pharmacotherapies.

Main Results:

• Established cardiac risk indices have varying strengths and weaknesses for predicting MACE.
• Noninvasive and invasive cardiac testing play a role in risk stratification, guiding further management.
• Perioperative pharmacotherapies can mitigate cardiovascular risk in select patients.

Conclusions:

• A comprehensive approach to risk stratification and optimization is vital for patients undergoing major vascular surgery.
• Tailoring cardiac evaluation and medical management based on individual risk factors improves patient safety.
• Further research is needed to refine risk prediction models and therapeutic strategies.